Drossapharm Asia (Viet Nam) Co., Ltd. is a specialized trading and processing company based in Hung Yen, Vietnam. Established in 2011, the company has grown into a regional leader in Southeast Asia, focusing on the production and marketing of natural casings and pharmaceutical precursors. Its core operations involve the processing of pig small intestines to produce salted sausage casings and the extraction and purification of crude heparin sodium from the intestinal mucosa. The heparin sodium is produced as a high-purity yellowish-white powder suitable for further chemical applications. Additionally, the company manages the import of industrial packaging materials, such as 100% new PP plastic packing strips in various colors. Drossapharm Asia operates with a workforce of 11 to 50 employees and maintains a robust international trade profile, with nearly 200 customs records involving a diverse network of global buyers and suppliers. The company is recognized for its consistent production quality and its dual role in the food processing and chemical precursor industries.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Curious about this supplier? Ask AI for a quick overview.
Key export market
🇻🇳 Vietnam🇻🇳 Vietnam
🇮🇹 Italy🇮🇹 Italy
🇨🇭 Switzerland🇨🇭 Switzerland
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customers
Top 5 customers
This insight is only available in the Pro plan
Top 5 export countries
Reflecting the supplier's export experience in target countries
Top 5 export countries
This insight is only available in the Pro plan
Shipment count distribution
Reflecting the supplier's market business activity
All categories
Loading chart data...
Shipment count distribution
This insight is only available in the Pro plan
Export weight distribution (kg)
Reflecting the supplier's export scale
All categories
Loading chart data...
Export weight distribution (kg)
This insight is only available in the Pro plan
Export weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughs
All categories
Loading chart data...
Export weight trend (kg)
This insight is only available in the Pro plan
CIF trend (USD)
For identifying high-value cooperation periods and single order value changes
All categories
Loading chart data...
CIF trend (USD)
This insight is only available in the Pro plan
Similar suppliers you may like
Hasan-Dermapharm Co., Ltd.
🇻🇳 Vietnam
2004501-1000 peopleManufacturer/Distributor
High capacity factory
Established brand
Own brand
High-tech enterprise
Key market
🇰🇭 Cambodia
Description
Hasan-Dermapharm Co., Ltd. is a leading pharmaceutical manufacturer and distributor based in Thuan An, Vietnam. Established in 2004 as a joint venture with Germany's Dermapharm AG, the company operates as a pioneer in the Vietnamese pharmaceutical industry, employing between 501 and 1000 professionals. The company specializes in the research, development, and commercialization of high-quality prescription drugs, health supplements, and vitamins, utilizing over 100 active ingredients across its diverse product portfolio.
Operating a state-of-the-art factory, Hasan-Dermapharm was among the first in Vietnam to achieve WHO-GMP, GLP, and GSP certifications. The company is currently expanding its manufacturing capabilities with a new plant designed to meet EU-GMP standards. Their core specializations include cardiovascular drugs, diabetes medications, neurological treatments, and dyslipidemia medications. They are particularly recognized for their expertise in advanced formulations, such as prolonged-release and micronized products, including Nifedipin Hasan 20 Retard and Hafenthyl Supra 160.
As a contract manufacturer and OEM provider, Hasan-Dermapharm leverages technology transferred from its German partners and maintains a dedicated R&D department managed by European specialists. The company conducts rigorous bioequivalence studies to ensure its products meet international efficacy standards, including some aligned with US-FDA guidelines. Beyond its strong presence in the Vietnamese market through major pharmacy chains, the company has been active in international trade since 2008, exporting its pharmaceutical formulations to various global markets.
GABAHASAN 300
BIHASAL 5
HASANLOR 5
FORMINHASAN 850
HASANFLON 500
SUCRAHASA 1g
HAFENTHYL SUPRA 160
HAFENTHYL 200
VasHasan MR
GLISAN 30 MR
TilHasan 60
Nifedipin Hasan 20 Retard
DHG Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
19742001-5000 peopleManufacturer/Distributor
High capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
4718
Key customer
PANACO
Key market
🇻🇳 Vietnam
Description
DHG Pharmaceutical Joint Stock Company (DHG Pharma) is a leading pharmaceutical manufacturer and distributor based in Can Tho, Vietnam. With a history spanning over 40 years, the company has established itself as a top-tier player in the industry, employing between 2,001 and 5,000 professionals. DHG Pharma operates advanced manufacturing facilities that hold prestigious Japan-GMP and EU-GMP certifications, producing a diverse portfolio of over 300 products across 12 therapeutic groups, including antibiotics, analgesics, cardiovascular drugs, and dietary supplements. Their well-known brands include Hapacol, Klamentin, and Naturenz, with many products recognized for bioequivalence.
As a publicly listed company recognized by Forbes Vietnam for over a decade, DHG Pharma maintains a robust distribution network serving more than 30,000 customers, including hospitals and pharmacies nationwide. The company offers OEM services and has formed strategic alliances with international partners like the Taisho Group to enhance its technological capabilities and expand its presence in the Asian market. DHG Pharma is committed to innovation and quality, consistently ranking as a top workplace and a premier provider of healthcare solutions in Vietnam.